Advanced Micro Devices offers a strong setup for put-selling strategies with solid fundamentals and data center growth ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has ...

Advanced Micro Devices, Inc. continues to show strong growth, especially in AI and data center segments. Learn more about AMD ...

The gross proceeds from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by Outlook Therapeutics are expected to be approximately $13.0 million.

Advanced Micro Devices (AMD) has been on a tear lately. Over the past month, the stock has surged about 32%, with a healthy 6 ...

US stock futures slide after Moodys downgraded the countrys credit rating from “Aaa” to “Aa1,” raising alarm over Americas ...

Poor breadth is mirrored in the percentage of total shares traded that are falling versus those rising. On the NYSE, ...

Intel Corporation, Qualcomm Incorporated, Advanced Micro Devices Inc. Read 's Market Analysis on Investing.com ...

Advanced Micro Devices (NASDAQ: AMD) is an important player in the global semiconductor industry as its chips power multiple ...

AMD stock is down nearly 50%, but explosive growth in AI, gaming, and data centers could make it one of 2025's biggest ...

Advanced Micro Devices Inc. (NASDAQ: AMD) shares were up nearly 2% on Wednesday before pulling back as the broader market ...

AMD is seen as an also-ran in the market for AI chips. But a BofA analyst thinks the company can still capture meaningful ...